Ibrutinib treatment via alternative administration in a patient with chronic lymphocytic leukemia and dysphagia.
DiSogra KY, Tran T, Arnall JR, Janes A, Moore DC, Park SI. Ibrutinib treatment via alternative administration in a patient with chronic lymphocytic leukemia and dysphagia. J Oncol Pharm Pract. 2021 Jul; 27(5):1265-1269.